RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection

被引:3
|
作者
Talukder, Pratik [1 ]
Chanda, Sounak [1 ]
机构
[1] Univ Engn & Management, Dept Biotechnol, St 03,Act Area 3,B-5, Kolkata 700156, W Bengal, India
关键词
COVID-19; Vaccine; ACE2; receptors; Antibody; Antigen; siRNA; Gene silencing; RESPIRATORY SYNDROME CORONAVIRUS; SARS-COV; PROTEIN; IDENTIFICATION; NANOCARRIERS; MODEL; MICE;
D O I
10.1007/s12010-021-03548-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Coronavirus disease of 2019 (COVID-19) pandemic, taking place globally, occurs as a result of the SARS-CoV-2 viral infection which has caused death of innumerable numbers of people and is responsible for a massive drop in the global economy. Millions of people are infected, and the death rate is also quite high in different countries. So, there is an urgent requirement of the invention of some effective and efficient drugs that can be effective against this deadly viral infection. The invention of new drugs and vaccine has become a matter of utmost importance to stop the mayhem of coronavirus pandemic. In the middle of such a deadly pandemic, the necessity of development of a vaccine is of high importance in this context. Among all the popular methods of vaccine development, the mRNA vaccines turned out to be the one of the most versatile vaccine with quick responses. However, in this review, we have explained all the possible types of vaccines available including DNA vaccines, RNA vaccines, and live and attenuated vaccines. Their effectiveness, importance, and application of the vaccines against the SARS-CoV-2 virus have been discussed. Research is also being conducted in the field of gene silencing, and one of the best possible ways to combat the virus at the molecular level is by applying RNAi technology. The modified siRNA molecules can be used to silence the gene expression of the virus. A summarization of the virus's behavior, characteristics, and the methods by which RNAi technology can be administered to control the virus is depicted in this study.
引用
收藏
页码:1744 / 1756
页数:13
相关论文
共 50 条
  • [1] RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection
    Pratik Talukder
    Sounak Chanda
    Applied Biochemistry and Biotechnology, 2021, 193 : 1744 - 1756
  • [2] Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
    Awadasseid, Annoor
    Wu, Yanling
    Tanaka, Yoshimasa
    Zhang, Wen
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 137
  • [3] Immune Response to SARS-CoV-2 Vaccines
    Bellamkonda, Navya
    Lambe, Upendra Pradeep
    Sawant, Sonali
    Nandi, Shyam Sundar
    Chakraborty, Chiranjib
    Shukla, Deepak
    BIOMEDICINES, 2022, 10 (07)
  • [4] SARS-CoV-2 virus: Vaccines in development
    Huang, Qingrui
    Yan, Jinghua
    FUNDAMENTAL RESEARCH, 2021, 1 (02): : 131 - 138
  • [5] Mapping the technological landscape of SARS, MERS, and SARS-CoV-2 vaccines
    Nascimento Junior, Jose Adao Carvalho
    Santos, Anamaria Mendonca
    Cavalcante, Rafael Ciro Marques
    Quintans-Junior, Lucindo Jose
    Walker, Cristiani Isabel Bandero
    Borges, Lysandro Pinto
    Frank, Luiza Abrahao
    Serafini, Mairim Russo
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2021, 47 (04) : 673 - 684
  • [6] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [7] A Possible Path towards Rapid Development of Live-Attenuated SARS-CoV-2 Vaccines: Plunging into the Natural Pool
    Todorov, German
    Uversky, Vladimir N.
    BIOMOLECULES, 2020, 10 (10)
  • [8] Overview of Nonhuman Primate Models of SARS-CoV-2 Infection
    Trichel, Anita M.
    COMPARATIVE MEDICINE, 2021, 71 (05) : 411 - 432
  • [9] The variants of SARS-CoV-2 and the challenges of vaccines
    Han, Xiucui
    Ye, Qing
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1366 - 1372
  • [10] Advanced Materials for SARS-CoV-2 Vaccines
    Mabrouk, Moustafa T.
    Huang, Wei-Chiao
    Martinez-Sobrido, Luis
    Lovell, Jonathan F.
    ADVANCED MATERIALS, 2022, 34 (12)